Presenters:
From PCOS to PMOS: What’s behind the name change?
Belmar Pharma Solutions presents this educational webinar to help providers gain a better understanding of the transition from ovarian PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS).
In This Webinar, You Will Learn:
- The significance of the name change, and why the focus is now on the metabolic and endocrine system
- Why PMOS requires a systemic, multi-organ approach to diagnosis and therapy
- Gaps in the modern therapy landscape addressing PMOS
- Prescribing and dosing customized compounded medications for a systemic approach to PMOS
Presented by:
- Angela DeRosa, DO, MBA, CPE, Medical Director of Belmar Pharma Solutions
- Andi Roths, PharmD, Director of Women’s Health
Dr. DeRosa is an expert in diagnosing and treating female patients with conditions like PMOS and hormone deficiencies. Andi Roths is an expert in Women’s Health and compounded therapies.iginal content.
Watch PMOS Webinar Now
This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.

